Opus Genetics, Inc. · NASDAQ:IRD
Boxer Capital Management, LLC reported a 5.40% stake in Opus Genetics, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 16, 2026
Boxer Capital Management, LLC reported a 5.40% stake in Opus Genetics, Inc., 4,533,660 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 4,533,660
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Boxer Capital Management, LLC | 5.40% | 4,533,660 |
| Boxer Holdings, LP | 5.40% | 4,533,660 |
| Boxer Holdings GP, LLC | 5.40% | 4,533,660 |
| Aaron Davis | 5.40% | 4,533,660 |
Source
Download original · View original at SEC
Related
- Opus Genetics, Inc.
- Boxer Capital Management, LLC
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 16, 2026
- Schedule 13G · Cormorant Asset Management, LP · Nov 16, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Caligan Partners LP · Nov 16, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 12, 2026